Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
Marta Simone Giuseppe Lucisano the Italian Multiple Sclerosis Register
Background To compare Expanded Disability Status Scale (EDSS) trajectories over time between Multiple Sclerosis (MS) groups with pediatric (POMS), adult (AOMS) and late (LOMS) onset, and between patients with and without progression independent of relapse activity (PIRA).
Methods Patients with a first visit within 1 year from onset, =/+ 5-year follow-up and =/+1 visit every 6 months were selected from the Italian MS Register. Adjusted disability trajectories were assessed by longitudinal models for repeated measures. Comparisons between groups and between patients with and without PIRA in subgroups were performed by evaluating the yearly differences of mean EDSS score changes versus baseline (delta-EDSS). A first CDA event was defined as a 6-months confirmed disability increase from study baseline, measured by EDSS (increase =/+ 1.5 points with baseline EDSS=0;1.0 with baseline EDSS score =/- 5.0 and =/- 0.5 point with baseline EDSS>5.5). PIRA was defined as a CDA event occurring more than 90 days after and more than 30 days before the onset of a relapse.
Results 3777 MS patients (268 POMS, 3282 AOMS, 227 LOMS) were included. The slope of disability trajectories significantly diverged in AOMS vs POMS starting from the second year of follow-up (Year 2: delta2-EDSS 0.18 (0.05; 0.31), p=0.0054) and then mean delta2-EDSS gradually increased up to 0.23 (0.07; 0.39, p=0.004) at year 5. Patients with PIRA had significant (p<0.0001) steeper increase in EDSS scores than those without PIRA in all groups, although in POMS, the disability trajectories began to diverge later and at a lesser extent with delta-EDSS score of 0.48 vs 0.83 in AOMS and 1.57 in LOMS, at 3 years after the first PIRA.
Conclusions Age is relevant in determining disability progression in MS. POMS shows a less steep increase in EDSS scores over time than older patients. The effect of PIRA in accelerating EDSS progression is less pronounced in POMS than in AOMS and LOMS.